Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
February 12, 2020
Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes
Megan Melody, Najla Al Ali, Ling Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older Patients
Megan Melody, Andrew Kuykendall, David Sallman, et al.
Leukemia & Lymphoma
|
June 11, 2021
What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?
Rami Komrokji, Najla Al Ali, Eric Padron, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia
Dasom Lee, Akriti G Jain, Yehuda Deutsch, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia
Akriti G Jain, Somedeb Ball, Luis E Aguirre, et al.
Oncotarget
|
February 11, 2017
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
Thomas Prebet, Andrea Toma, Thomas Cluzeau, et al.
The Oncologist
|
November 10, 2017
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies
Rami Komrokji, Arlene S Swern, David Grinblatt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 19, 2014
Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome
Taiga Nishihori, Janelle Perkins, Asmita Mishra, et al.
Annals of Hematology
|
November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities
Nathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.
Haematologica
|
May 11, 2019
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia
Chetasi Talati, Varun C Dhulipala, Mar Tine Extermann, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
Clinical Lymphoma, Myeloma & Leukemia
|
February 12, 2020
Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes
Megan Melody, Najla Al Ali, Ling Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older Patients
Megan Melody, Andrew Kuykendall, David Sallman, et al.
Leukemia & Lymphoma
|
June 11, 2021
What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?
Rami Komrokji, Najla Al Ali, Eric Padron, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia
Dasom Lee, Akriti G Jain, Yehuda Deutsch, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia
Akriti G Jain, Somedeb Ball, Luis E Aguirre, et al.
Oncotarget
|
February 11, 2017
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
Thomas Prebet, Andrea Toma, Thomas Cluzeau, et al.
The Oncologist
|
November 10, 2017
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies
Rami Komrokji, Arlene S Swern, David Grinblatt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 19, 2014
Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome
Taiga Nishihori, Janelle Perkins, Asmita Mishra, et al.
Annals of Hematology
|
November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities
Nathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.
Haematologica
|
May 11, 2019
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia
Chetasi Talati, Varun C Dhulipala, Mar Tine Extermann, et al.
Page
of 13